http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CN-111929441-B
Outgoing Links
Predicate | Object |
---|---|
classificationCPCAdditional | http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/G01N2333-918 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/G01N2800-52 |
classificationCPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/G01N33-573 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/G01N33-57423 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/G01N33-57484 |
classificationIPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/G01N33-573 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/G01N33-574 |
filingDate | 2020-08-17-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
grantDate | 2022-10-21-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
publicationDate | 2022-10-21-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
publicationNumber | CN-111929441-B |
titleOfInvention | Biomarkers and kits used in lung cancer diagnosis and prognosis evaluation |
abstract | The invention discloses a biomarker and a kit used in lung cancer diagnosis and prognosis evaluation, belonging to the technical field of biomedicine. The biomarker used in lung cancer diagnosis and prognosis evaluation of the present application is ABHD4 gene. The present application confirms through experiments that ABHD4 protein is abnormally expressed in cancer tissues of patients with non-small cell lung cancer; Independent prognostic factors in patients with small cell lung cancer. Detection of ABHD4 protein expression in individual tissues can diagnose whether an individual has non-small cell lung cancer and evaluate the prognosis of patients, and provide decision support for clinical treatment. It can be seen that ABHD4 gene is used in the preparation of biomarkers and kits for lung cancer diagnosis and prognosis evaluation. will have a wide range of uses. |
priorityDate | 2020-08-17-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
type | http://data.epo.org/linked-data/def/patent/Publication |
Incoming Links
Total number of triples: 180.